|
|
 |
 |
 |
 |
 |
 |
|
|
|
 |
|
|
Microbiologics, Inc. Appoints New Chief Executive Officer |
|
|
 |
|
|
|
 |
 |
 |
|
 |
 |
|
|
 |
 |
|
 |
 |
 |
 |
|
 |
 |
|
|
|
|
Saint Cloud, Minnesota USA (September 1, 2010) Brad Goskowicz has been named Chief Executive Officer of Microbiologics, Inc., a global leader in producing biological reference materials for Quality Control testing. Previously, Brad had served as President and Chief Marketing Officer for the company.
Microbiologics was founded in 1971 as a laboratory testing facility specializing in environmental and public health threats. Today, the company is a leading manufacturer of lyophilized microorganism preparations for Quality Control testing in the Clinical, Pharmaceutical, Cosmetic, Food Quality, Educational, Water and Environmental Industries. There are currently more than 130 authorized Microbiologics Distributors serving approximately 120 countries around the world.
Brad Goskowicz joined Microbiologics in February of 2009 as the Chief Marketing Officer. Previously, Brad served in senior sales, marketing, and leadership positions with companies such as Johnson & Johnson, Medtronic, Thoratec, and Myocor. In addition, Brad has served as President of US Speedskating for the last four years. Since joining Microbiologics, he has led the market launch of EZ-Accu Shot™, Lab Elite Certified Reference Materials and other key initiatives.
Bob White, had been acting CEO since March and will continue to serve as Board Chair, a position he has held since January of 2008. “This completes the transition we began in the spring, and I am certain that Brad’s dedication and experience will ensure we continue our strong pattern of growth well into the future.”
In his new role, Goskowicz will be directing a strong Management Team of Frank Wohletz, Chief Financial Officer, Donna Scholer, Chief Operating Officer and Naomi Bowling, Vice President and General Manager of Microbiologics’ Gibson Laboratories subsidiary, which is based in Lexington, Kentucky.
“I continue to be encouraged and excited by all the opportunities for growth that we have with Microbiologics,” Goskowicz stated. “With the increased emphasis on key areas, such as food safety, clinical infection control, proficiency testing and biopharmaceuticals our markets continue to show healthy growth”.
Microbiologics is majority owned by St. Cloud, Minnesota based Granite Equity Partners. Granite Equity Partners invests human and financial capital from its community of investors, executives, and advisors to advance select companies toward their full potential.
About Microbiologics, Inc.:
The Mission of Microbiologics is to provide the highest quality biomaterials for a healthier, safer world. Microbiologics manufactures cost-effective, reliable, and convenient biological reference materials for Quality Control in microbiology labs. They specialize in manufacturing lyophilized microorganisms for clinical, pharmaceutical, cosmetic, food quality, educational, water and environmental laboratories. The company is ISO 9001:2008 certified and is accredited in accordance with ISO 17025:2005 and ISO Guide 34:2000. Additionally, Microbiologics has achieved FDA registration and CE Mark conformity. Currently, Microbiologics has an international distribution network of over 130 companies and ships to approximately 120 countries around the world.
Company Contact: Brad Goskowicz (320) 253-1640 (Office)
info@microbiologics.com • www.microbiologics.com
About Granite Equity Partners:
Granite Equity Partners is a private equity firm headquartered in St. Cloud, Minnesota. They govern companies, as trusted stewards, creating value for stakeholders, in turn enhancing the health of Greater Minnesota.
www.graniteequity.com
|
|
|
|
 |
 |
|
 |
 |
 |
 |
|
 |
 |
|
|
|
|
